Because CXCR5 is also expressed on Tfh cells, CXCR5 CAR-T cells offer an unprecedented opportunity to target the TME as well, a feature that was so far attributed to TCR-mediated effects on cross-presented tumor peptides in stromal cells. The gene discussed is CXCR5; the disease is neoplasm.